Histogen at the ISHRS conference

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Thinning87
    Senior Member
    • Dec 2012
    • 839

    Originally posted by Conpecia
    if the results were substantial enough you'd see photographs. there is no greater public venue than the internet. it makes no sense to be cryptic about a breakthrough unless you are at risk for intellectual property infringement, and a photo demonstrating dramatic regrowth poses no such threat. it would generate hype and all eyes would be on your company at any conference. we're not talking about studies or findings in a statistical sense, we're talking about a photograph showing cosmetic regrowth on a bald scalp. i'm actually curious as to any reason why they would not do that if they had mind-blowing results. anyone?

    it is safe to assume that there will not be any mind-blowing advancement coming from histogen. it's still an assumption, sure. but i'm trying to look out for newcomers to the forum and manage expectations, as one of the biggest letdowns of my life was when there was insane hype about replicel last year and the results were, well, inconsequential at best.

    that being said, i don't doubt we'll get "good" news from histogen. but i don't want people thinking we're all gonna be cured by 2015.
    I disagree I think any company that has a good product tries to hold up and not give out any information until the day they launch an effective marketing campaign before commercialization. They might benefit from rumors to get early adopters interested, but not by directly releasing any significant information without even having completed the clinical trials (since they don't fully know what the true potential of the product is and therefore they may set expectations too high or low and create confusion).

    Comment

    • Conpecia
      Senior Member
      • Sep 2011
      • 904

      Originally posted by Thinning87
      I disagree I think any company that has a good product tries to hold up and not give out any information until the day they launch an effective marketing campaign before commercialization. They might benefit from rumors to get early adopters interested, but not by directly releasing any significant information without even having completed the clinical trials (since they don't fully know what the true potential of the product is and therefore they may set expectations too high or low and create confusion).
      you know i agree with you. it just dawned on me that they could snap a pic of a full head of hair, then something could go terribly wrong, and they'd have the entire bald world expecting the cure and up in arms when they had to break the bad news.

      Comment

      • rdawg
        Senior Member
        • Jun 2012
        • 996

        Originally posted by Conpecia
        you know i agree with you. it just dawned on me that they could snap a pic of a full head of hair, then something could go terribly wrong, and they'd have the entire bald world expecting the cure and up in arms when they had to break the bad news.
        bingo, definitely could be a reason.

        anyway this place needs to be modded, I dont like coming on here to silly fights that go on for two pages.

        Keep this site informative and discussion based, let's not turn it into a shouting match.

        Comment

        • Thinning87
          Senior Member
          • Dec 2012
          • 839

          Originally posted by Conpecia
          you know i agree with you. it just dawned on me that they could snap a pic of a full head of hair, then something could go terribly wrong, and they'd have the entire bald world expecting the cure and up in arms when they had to break the bad news.
          Yes indeed - the value of the company is a function of the value of future sales - so messing things up by releasing too much data ahead of proper productr launch would be a mistake no one in any company wants to make.

          I frankly doubt Histogen will be it, but I do think it will be a good weapon if combined with other stuff. We'll find out I guess!

          But yeah, let's not expect some groundbreaking revelation at the congress, and let's keep in mind companies attend the number 1 reason why companies attend is business development.

          In particular Histogen needs a partner to licence the product to before they can launch it and finish clinical trials (SOURCE)... so in my opinion that is also the news we should look forward to, not so much final phase 2 results (which though may give us an idea of how long HSC effects will last).

          I think we all have to wait for phase 3 to have a definitive idea of what to expect from the product...

          Comment

          • koolx
            Senior Member
            • Oct 2010
            • 115

            Originally posted by Thinning87
            Yes indeed - the value of the company is a function of the value of future sales - so messing things up by releasing too much data ahead of proper productr launch would be a mistake no one in any company wants to make.

            But yeah, let's not expect some groundbreaking revelation at the congress, and let's keep in mind companies attend the number 1 reason why companies attend is business development.
            when is the congress?

            i think ur sugarcoating things. the company said they would release pics in feb regardless of what u speculate for its company strategy. by not doing so isnt smart company strategy - it could hurt its reputation.

            just to correct u with all due respect, a company's value is not based on the value of its future sales, its based on the value of its expected future sales.. just letting u know.

            Comment

            • hellouser
              Senior Member
              • May 2012
              • 4419

              Originally posted by koolx
              when is the congress?

              i think ur sugarcoating things. the company said they would release pics in feb regardless of what u speculate for its company strategy. by not doing so isnt smart company strategy - it could hurt its reputation.

              just to correct u with all due respect, a company's value is not based on the value of its future sales, its based on the value of its expected future sales.. just letting u know.
              Youre not in any position to make any kind of judgement of what constitutes right or wrong launch strategies. You're not a CEO and going by your comments in the forum, you've got the IQ of a fvcking rock.

              Comment

              • Thinning87
                Senior Member
                • Dec 2012
                • 839

                Originally posted by koolx
                when is the congress?

                i think ur sugarcoating things. the company said they would release pics in feb regardless of what u speculate for its company strategy. by not doing so isnt smart company strategy - it could hurt its reputation.
                Again - Ziering (an outside consultant for the company) said he planned on having some pictures in February. That is not the same of what you're saying, and everytime I point that out to you, you just start insulting me and the conversation gets stuck with you producing no logical feedback.

                Originally posted by koolx
                just to correct u with all due respect, a company's value is not based on the value of its future sales, its based on the value of its expected future sales.. just letting u know.
                The value of the company NOW is based on expected future sales, correct, but the most recent sources show they do not intend to sell before product launch - hence it is correct to just talk about future sales affecting the future value of the company.

                Comment

                • koolx
                  Senior Member
                  • Oct 2010
                  • 115

                  Originally posted by Thinning87
                  Again - Ziering (an outside consultant for the company) said he planned on having some pictures in February. That is not the same of what you're saying, and everytime I point that out to you, you just start insulting me and the conversation gets stuck with you producing no logical feedback.

                  The value of the company NOW is based on expected future sales, correct, but the most recent sources show they do not intend to sell before product launch - hence it is correct to just talk about future sales affecting the future value of the company.
                  sounds good.. thanks.

                  Comment

                  • Jairus
                    Senior Member
                    • Feb 2012
                    • 191

                    How will Histogen affect a receding hairline?

                    Will we still need to use DHT blockers?

                    Comment

                    • rdawg
                      Senior Member
                      • Jun 2012
                      • 996

                      Originally posted by Jairus
                      How will Histogen affect a receding hairline?

                      Will we still need to use DHT blockers?
                      Ziering stated and you could see from some of the 6th month pictures that most if not all vellus hairs should return to terminal, even in the receding hairline.

                      That one women practically grew her entire hairline back due to having a lot of vellus hairs, but in fairness the other results werent as good as hers(at the 6-7 month mark).

                      So i'd say it would do alot if you catch the loss early on, later I'm not so sure, and IMO yes a DHT blocker is still needed, but we'll see if that's still the case when they test out more frequent doses.

                      Comment

                      • Pentarou
                        Senior Member
                        • Apr 2013
                        • 482

                        Compoundability is the key issue with Histogen. If more injections = more regrowth, it'll be a genuine superweapon against AGA.

                        Comment

                        • Thinning87
                          Senior Member
                          • Dec 2012
                          • 839

                          Originally posted by Pentarou
                          Compoundability is the key issue with Histogen. If more injections = more regrowth, it'll be a genuine superweapon against AGA.
                          Yes indeed! We all know it's a great weapon already, but IMO those above 15 years old now cannot rely on it solely because it will be released in some years.... I still haven't given up on Aderans, if only one of these alternative companies were able to deliver something within the next 5 years, we'd virtually have results comparable to those of a cure...

                          Comment

                          • Pentarou
                            Senior Member
                            • Apr 2013
                            • 482

                            I really don't think that ARI is going anywhere. All we can hope for is that if it goes under, it doesn't take lots of useful patentable concepts down with it, as happened with Intercytex.

                            Comment

                            Working...